Dr. Aljuhani is a physician-scientist in training, currently a Breast Medical Oncology Fellow at Princess Margaret Cancer Centre (University Health Network) and an MSc candidate in Clinical Epidemiology and Healthcare Research at the University of Toronto. She will be joining KFSH&RC in Riyadh as a Consultant Physician-Scientist while pursuing a PhD in Biomedical Science
Amal Aljuhani
University: Princess Margaret Cancer Centre
Supervisor: Dr. Michelle B. Nadler
Dr. Samuel (Sze Wah) Chan, MD, FRCPC, is a medical oncology clinical-research fellow at the Juravinski Cancer Centre and McMaster University. He has a clinical interest in genitourinary and thoracic oncology, with a strong focus on immunotherapy, real-world outcomes research, and clinical trials.
Samuel Chan
University: McMaster University Juravinski Cancer Centre
Supervisor: Dr. Ani Kartolo
Nihar Desai is an allogeneic stem cell transplant physician at the Princess Margaret Cancer Centre Toronto. He is an incoming faculty member in the Division of Myeloid Malignancies and Transplantation at Allegheny Health Network, Pittsburgh USA. His research interests lie in the optimization of post-transplant cyclophosphamide (PTCy) dosing and the evaluation of combination GVHD prophylaxis strategies incorporating ATG and PTCy.
Nihar Desai
University: Princess Margaret Cancer Centre
Supervisor: Dr. Rajat Kumar
Fernando Pikabea Diaz MD is a Thoracic Medical Oncology Fellow at Princess Margaret Cancer Centre / University Health Network in Toronto, Canada. His research focuses on ultrasensitive ctDNA-based minimal residual disease detection and translational biomarkers in early-stage non-small cell lung cancer.
Fernando Pikabea Diaz
University: Princess Margaret Cancer Centre
Supervisor: Dr. Natasha B. Leighl
Dr. François Jobin Gervais MD received his medical degree from Université Laval in Québec City, where he also completed his residency programs. He is certified in both medical oncology and hematology. He recently completed his fellowship in gastrointestinal oncology at The Princess Margaret Cancer Centre in Toronto and now holds a staff position at L’Hôtel-Dieu de Lévis-CISSS Chaudière-Appalaches.
François Jobin-Gervais
University: Princess Margaret Cancer Centre
Supervisors: Dr. Eric Xueyu Chen
Dr. Malek B. Hannouf, MD, PhD is completing his medical oncology training at the University of Calgary. Previously he completed a PhD in Cancer Epidemiology from the School of Medicine at Western University. His main research focuses on medical decision making, health economics, health technology assessment and real-life outcomes to study the efficacy and cost-effectiveness of new oncology technologies in an innovative health technology assessment framework of translational and multidisciplinary research. He has published extensively in this area which enabled the development of effective provincial policies leading to the integration of clinically promising new approaches for cancer patients into the health care system.
Malek Hannouf
University: University of Calgary
Supervisor: Dr. Richard Lee Ying
Anna-Maria Lazaratos is an MD-PhD candidate at Université de Montréal, conducting her doctoral work at the Goodman Cancer Institute under the supervision of Dr. Peter Siegel. Her research focuses on the tumor immune microenvironment in triple negative breast cancer, with an emphasis on immunotherapy resistance and the development of novel therapeutic strategies.
Anna-Maria Lazaratos
University: McGill University
Supervisor: Dr. Peter Siegel
Chloe Lim is a PGY-5 Medical Oncology resident at BC Cancer Vancouver and the University of British Columbia, with research interests in real-world outcomes in advanced melanoma patients. This fall, she will be joining BC Cancer Surrey as a staff oncologist, treating patients with GI, thoracic, and skin malignancies.
Chloe Lim
University: BC Cancer Agency
Supervisor: Dr. Alison Weppler
Syed Irteza Shamsi is a researcher in real-world evidence oncology specializing in statistical methods and outcome analysis. He has a bachelor's in science in Mathematical Sciences from the University of British Columbia and is currently working under Dr. Winson Cheung in the Oncology Outcomes lab in Calgary, Alberta.
Syed Irteza Abbas Shamsi
University: University of Calgary
Supervisor: Dr. Winson Cheung
Luxiga Thanabalachandran is a medical student and researcher with interests in oncology, quality improvement, and the responsible use of artificial intelligence in healthcare. Her work explores how AI-supported summarization can improve documentation, efficiency, and communication in multidisciplinary cancer conferences. She is honoured to be recognized by NOYCIA and hopes to continue contributing to innovations that make cancer care more timely, accurate, and patient-centred.